Transamerica Financial Advisors’s Avanos Medical AVNS Stock Holding History

Transamerica Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174	Hold	7	–	–	﹤0.01%	1898
2026 Q1	$98	Hold	7	–	–	﹤0.01%	1750
2025 Q4	$79	Sell	7 -81	-92%	-$927	﹤0.01%	1708
2025 Q3	$1.02K	Buy	+88	New	+$1.03K	﹤0.01%	1166
2016 Q2	–	Sell	-73	Closed	-$3K	–	413
2016 Q1	$3K	Sell	73 -50	-41%	-$1.33K	﹤0.01%	640
2015 Q4	$5K	Hold	123	–	–	﹤0.01%	666
2015 Q3	$4K	Sell	123 -104	-46%	-$3.63K	﹤0.01%	663
2015 Q2	$10K	Sell	227 -264	-54%	-$11.8K	﹤0.01%	628
2015 Q1	$25K	Sell	491 -444	-47%	-$20.6K	﹤0.01%	508
2014 Q4	$43K	Buy	+935	New	+$36.7K	﹤0.01%	371

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Transamerica Financial Advisors's AVNS Position: Q2 2026 in Review

Transamerica Financial Advisors held its Avanos Medical (AVNS) position steady in Q2 2026 at 7 shares worth $174. The position accounts for ﹤0.01% of the portfolio, ranked #1898.

Transamerica Financial Advisors first reported a position in AVNS in Q4 2014 and has held it in 10 quarters since. The position peaked at $43K in Q4 2014. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Transamerica Financial Advisors held 7 shares of Avanos Medical worth $174 as of Q2 2026.
Transamerica Financial Advisors left its Avanos Medical share count unchanged in Q2 2026.
Avanos Medical made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1898 holding.
Transamerica Financial Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 10 quarters since.
Transamerica Financial Advisors's Avanos Medical position peaked at $43K in Q4 2014.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.